Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cresco Labs (CRLBF) Shares Outstanding (Diluted Average) (2020 - 2023)

Cresco Labs filings provide 3 years of Shares Outstanding (Diluted Average) readings, the most recent being $323.8 million for Q4 2023.

  • On a quarterly basis, Shares Outstanding (Diluted Average) changed N/A to $323.8 million in Q4 2023 year-over-year; TTM through Dec 2023 was $323.8 million, a N/A change, with the full-year FY2023 number at $323.8 million, changed N/A from a year prior.
  • Shares Outstanding (Diluted Average) hit $323.8 million in Q4 2023 for Cresco Labs, up from $1190.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $323.8 million in Q4 2023 to a low of $230.0 in Q3 2020.
  • Median Shares Outstanding (Diluted Average) over the past 3 years was $1190.0 (2021), compared with a mean of $107.9 million.
  • The widest YoY moves for Shares Outstanding (Diluted Average): up 417.39% in 2021, down 417.39% in 2021.
  • Cresco Labs' Shares Outstanding (Diluted Average) stood at $230.0 in 2020, then skyrocketed by 417.39% to $1190.0 in 2021, then skyrocketed by 27211645.04% to $323.8 million in 2023.
  • The last three reported values for Shares Outstanding (Diluted Average) were $323.8 million (Q4 2023), $1190.0 (Q3 2021), and $230.0 (Q3 2020) per Business Quant data.